Private Placement

Nasdaq-listed Eightco reveals a massive treasury, holding nearly 10% of Worldcoin's supply in a strategic move to dominate the future of human verification.

Clean-tech innovator FuelPositive faces scrutiny for delaying its AGM, raising questions about governance as it races to revolutionize farming with green ammonia.

Beijing lowers its GDP goal to 4.5-5%, the lowest in decades, signaling a strategic shift to tackle domestic risks and foster high-tech innovation.

A Hong Kong professor's tech, inspired by desert ants, is cooling cities globally without electricity, slashing energy use and carbon emissions.

Recycling giant ATRenew appoints a JD.com investment director to its board, signaling a major move to dominate China's booming circular economy.

A new report reveals Gen Z women are rejecting old labels and hustle culture, prioritizing mental health, authentic living, and tech on their own terms.

Genesis Land Development saw record revenues in 2025, but a drop in new orders and a cautious outlook reveal a strategy for a cooling Calgary market.

NeuroPace will present its RNS System at the Leerink conference, a key moment for the company to showcase its epilepsy treatment to top investors.

Major deals with Cadillac and Ferrari mark a pivotal year for Research Frontiers, but can its smart glass tech overcome growing financial losses?

NextCure accelerates its high-stakes ovarian cancer drug trial, but with cash dwindling, can it reach the finish line before time runs out?

Inuvo's stock faces uncertainty as a strategic pivot causes a steep Q4 revenue drop, betting its future on its privacy-focused IntentKey AI technology.

With a fresh $72M in financing, Canadian innovator Activate is betting big on its unique blend of physical gaming to build a global entertainment empire.

The Bloomberg 500 adds 11 tech-heavy firms like Nebius Group and ASTS, signaling a major shift in market leadership driven by AI and digital infrastructure.

With a major new investment, Cognito Therapeutics is pushing its non-invasive light and sound therapy for Alzheimer's toward a 2027 market launch.

BioRestorative Therapies is leveraging its clinical-grade regenerative medicine to disrupt the aesthetics industry. Can science beat marketing?

With a melanoma drug on track for 2027 and a deep pipeline, Immatics' 2025 net loss is part of a larger strategy to dominate PRAME cancer therapy.

OmniAb reported declining revenue and a wider net loss for 2025, even as it launched its revolutionary OmniUltra platform and its partners' drugs advance.

Yarbo's all-season yard robot hit $1M on Kickstarter in record time, signaling a major shift in how we manage our lawns, gardens, and driveways.

After a four-year regulatory journey, AquaBoreal's massive salmon farm gets key approval, promising to boost Quebec's food security and revitalize a region.

Strong investor demand leads to upsized funding, set to accelerate drilling at the high-grade Ballywire project, heralded as Ireland's next big mineral find.